Post-pandemic Era Global Emergency Contraceptives Market Segment Research Report 2024
Published on: 2024-01-04 | No of Pages : 212 | Industry : Medical Devices & Consumables Research Center
Publisher : XMR | Format : PDF
Post-pandemic Era Global Emergency Contraceptives Market Segment Research Report 2024
Summary
The global economy is expected to expand 5.6% in 2021,global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic ProspectsGrowth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global Emergency Contraceptives market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to MR Accuracy Reports analysis, The segment in Emergency Contraceptives market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Emergency Contraceptives production is XX (K Units). US market value in 2021 is about USD XX billion, and US Emergency Contraceptives production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Emergency Contraceptives production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Emergency Contraceptives Market by MR Accuracy Reports Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Emergency Contraceptives Market?
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
...
Major Type of Emergency Contraceptives Covered in MR Accuracy Reports report
Combined estrogen and progestin pills
Progestin-only (as Levonorgestrel) pills
Antiprogestin (as mifepristone) pills
Ulipristal acetate pills
Application Segments Covered in MR Accuracy Reports Market
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
The global economy is expected to expand 5.6% in 2021,global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic ProspectsGrowth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global Emergency Contraceptives market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to MR Accuracy Reports analysis, The segment in Emergency Contraceptives market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Emergency Contraceptives production is XX (K Units). US market value in 2021 is about USD XX billion, and US Emergency Contraceptives production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Emergency Contraceptives production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Emergency Contraceptives Market by MR Accuracy Reports Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Emergency Contraceptives Market?
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
...
Major Type of Emergency Contraceptives Covered in MR Accuracy Reports report
Combined estrogen and progestin pills
Progestin-only (as Levonorgestrel) pills
Antiprogestin (as mifepristone) pills
Ulipristal acetate pills
Application Segments Covered in MR Accuracy Reports Market
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others
For any other requirements, please feel free to contact us and we will provide you customized report.